These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35652493)

  • 1. High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020.
    Faine BA; Rech MA; Vakkalanka P; Gross A; Brown C; Harding SJ; Slocum G; Zimmerman D; Zepeski A; Rewitzer S; Howington GT; Campbell M; Dawson J; Treu CN; Nelson L; Jones M; Flack T; Porter B; Sarangarm P; Mattson AE; Bailey A; Kelly G; Talan DA
    Acad Emerg Med; 2022 Sep; 29(9):1096-1105. PubMed ID: 35652493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for extended-spectrum β-lactamase producing antimicrobial-resistant
    Omar MH; Kilale AM; Rashid HK; Mwakapeje ER; Onoka IM; Gimbi AA
    Pan Afr Med J; 2024; 47():193. PubMed ID: 39119113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1).
    Talan DA; Takhar SS; Krishnadasan A; Abrahamian FM; Mower WR; Moran GJ;
    Emerg Infect Dis; 2016 Sep; 22(9):1594-603. PubMed ID: 27532362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients.
    Mitrani-Gold FS; Kaye KS; Gupta V; Mulgirigama A; Trautner BW; Scangarella-Oman NE; Yu KC; Ye G; Joshi AV
    PLoS One; 2023; 18(5):e0285427. PubMed ID: 37167277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and predictors of extended spectrum B-lactamase urinary tract infections among emergency department patients: A retrospective chart review.
    Bou Chebl R; Assaf M; Kattouf N; Abou Arbid S; Haidar S; Geha M; Makki M; Tamim H; Abou Dagher G
    Am J Emerg Med; 2021 Nov; 49():304-309. PubMed ID: 34182275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
    Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli in emergency department.
    Lee H; Han SB; Kim JH; Kang S; Durey A
    Am J Emerg Med; 2018 Sep; 36(9):1608-1612. PubMed ID: 29373168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka.
    Priyadharshana U; Piyasiri LB; Wijesinghe C
    Ceylon Med J; 2019 Dec; 64(4):140-145. PubMed ID: 32120467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmidic Fluoroquinolone Resistance Genes in Fluoroquinolone-Resistant and/or Extended Spectrum Beta-Lactamase-Producing
    Akgoz M; Akman I; Ates AB; Celik C; Keskin B; Ozmen Capin BB; Karahan ZC
    Microb Drug Resist; 2020 Nov; 26(11):1334-1341. PubMed ID: 32407158
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.
    He XT; Chang CN; Yu CH; Wang CC
    Pediatr Neonatol; 2024 May; 65(3):242-248. PubMed ID: 37951832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Extended-Spectrum β-Lactamase Urinary Tract Infections Among Hospitalized Emergency Department Patients in the United States.
    Talan DA; Takhar SS; Krishnadasan A; Mower WR; Pallin DJ; Garg M; Femling J; Rothman RE; Moore JC; Jones AE; Lovecchio F; Jui J; Steele MT; Stubbs AM; Chiang WK; Moran GJ
    Ann Emerg Med; 2021 Jan; 77(1):32-43. PubMed ID: 33131912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU).
    Choe HS; Lee SJ; Cho YH; Çek M; Tandoğdu Z; Wagenlehner F; Bjerklund-Johansen TE; Naber K;
    J Infect Chemother; 2018 Apr; 24(4):278-283. PubMed ID: 29292177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections.
    Zatorski C; Zocchi M; Cosgrove SE; Rand C; Brooks G; May L
    BMC Infect Dis; 2016 Nov; 16(1):638. PubMed ID: 27814677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.